Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Coya Therapeutics Inc (COYA)

Coya Therapeutics Inc (COYA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Coya Therapeutics Inc 5850 San Felipe St Suite 500 HOUSTON TX 77057 USA

www.coyatherapeutics.com Employees: 8 P: 800-587-8170

Sector:

Medical

Description:

Coya Therapeutics Inc. is a clinical-stage biotechnology company. It involved in developing proprietary treatments focused on the biology and potential therapeutic advantages of regulatory T cells to target systemic inflammation and neuroinflammation. The company's therapeutic platforms include Treg-enhancing biologics, Treg-derived exosomes, and autologous Treg cell therapy. Coya Therapeutics Inc. is based in HOUSTON.

Key Statistics

Overview:

Market Capitalization, $K 116,128
Enterprise Value, $K 77,788
Shares Outstanding, K 20,924
Annual Sales, $ 3,550 K
Annual Net Income, $ -14,880 K
Last Quarter Sales, $ 3,560 K
Last Quarter Net Income, $ -2,120 K
EBIT, $ -20,580 K
EBITDA, $ -20,550 K
60-Month Beta 0.20
% of Insider Shareholders 12.00%
% of Institutional Shareholders 39.75%
Float, K 18,413
% Float 88.00%
Short Interest 476
Short Float 2.28%
Short Volume Ratio 0.12

Growth:

1-Year Return -1.65%
3-Year Return 17.14%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.10 on 11/12/25
Next Earnings Date 03/17/26
Earnings Per Share ttm -1.08
EPS Growth vs. Prev Qtr 72.22%
EPS Growth vs. Prev Year 61.54%
Annual Dividend & Yield 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

COYA Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -55.76%
Return-on-Assets % -48.35%
Profit Margin % -419.15%
Debt/Equity 0.00
Price/Sales 31.73
Price/Cash Flow N/A
Price/Book 3.31
Book Value/Share 1.63
Interest Coverage -0.75
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar